Interestingly, we found that a large number of immune-related pathways were positively correlated with TMSB10 in a variety of cancers, such as GBM, LGG, sarcoma (SARC), breast invasive carcinoma (BRCA), skin cutaneous melanoma (SKCM), kidney renal clear cell carcinoma (KIRC), thyroid carcinoma (THCA) and pheochromocytoma and paraganglioma (PCPG) (Fig. 2B). Here, TMSB10 is linked to glioblastoma.